revenu beat consensu although major beat rel
forecast driven revenu recognit panorama horizon revenu
also exceed estim due stronger anticip volum guidanc
reiter increasingli view risk/reward attract base momentum
potenti mileston line valuat p-t
out-performance driven agreement pano hc volum also contribut
revenu y/i forecast
consensu out-performance primarili attribut non-product revenu
came forecast due larger anticip revenu qiagen
agreement addit robust volum growth drove panorama horizon revenu
exceed forecast respect product revenu
evercord vistara came light expect hindsight
aggress model slope evercord ramp
gross margin forecast consensu rel
forecast beat driven higher expect revenu well cogs/
test come lower anticip sg expens
lighter forecast percentag sale manag reiter full year revenu
guidanc consensu
solid quarter even exclud benefit payment
despit shift accrual-bas revenu recognit fact repres
largest sequenti volum growth quarter histori compani benefit
new product new account improv user experi believ
driver persist therefor meet guidanc look achiev
overal view risk/reward increasingli attract base compani
aforement momentum head potenti import pipelin
mileston partnership agreement next month accordingli
rais price target ev/sal premium peer
pleas see page report import disclosur
nipt market current estim opportun potenti
expand measur volum nipt becom well adopt averag risk
segment well posit capit opportun believ current
lead us nipt provid compani larg sale forc target us
averag risk market also abl leverag nipt sale forc cross-
sell opportun product reproduct medicin addit natera
cloud-bas bioinformat platform provid global reach enabl compani
effici achiev scale compani grow long-term strategi also attract
sinc core technolog could posit compani well potenti massiv
massiv base case
cross sell rate panorama
product line expect
averag risk nipt guidelin inclus
reimburs occur sooner
cross sell rate product higher
anticip
reimburs occur later
clinic valid microdelet
establish payment remain low
success constel sale allow
price eros continu nipt
scale improv margin
high risk growth moder
genet test diagnost compani develop
commerci non-invas method analyz dna use massiv multiplex
pcr mmpcr approach predict algorithm compani offer proprietari genet
test servic reproduct medicin concept natera product includ
panorama non-invas prenat screen test nipt horizon carrier screen
inherit diseas test field reproduct genet compani offer
major test clia lab also offer cloud-bas softwar call
constel allow global laboratori access bioinformat platform
futur compani plan launch sever liquid biopsi test use mmpcr
technolog cancer diagnost
cowen compani
cowen vs consensu mm except revenu revenu metric mm except test access asp revenu volum base test volum base test product volum base test statement mm except growth per count revenu y/i forecast consensu out-performance primarili driven better expect licens revenu forecast due larger activ front payment panorama horizon revenu forecast product revenu light horizon revenu y/i forecast hc test access forecast asp expect expens light forecast percent sale sg expens forecast absolut basi materi expect percent sale gross margin forecast driven higher expect revenu well lower expect cogs/test panorama revenu y/i forecast beat seem driven stronger expect volum quarter test forecast although light expect product revenu light forecast commentari limit manag indic cord blood revenu track line expect like aggress model evercord revenu ramp total test access test forecast driven panorama horizon out-performance asp line forecast cowen
compani report cowen compani
cagrcommentstot revenu reiter growth assum small contribut qiagenproduct panorama horizon royalti incom pat partnership revenuetot test access constel volumesgrowth msd q/q growth test access next yearstot asp base test revenu recogn upon deliveri basisgrowth test access volum growth percent total base test rapid chang average risk polici contempl guidancehorizon carrier screen revenu recogn upon deliveri basisgrowth test access volum growth percent total base test recogn upon deliveri basisgrowth test volum growth percent total base test revenu new product reiter growth volum growth access panorama attach volum growth establish code cowen
compani report thomson eikon cowen compani
revenu access target next year possibl reiter gross gross margin develop expect reiter sg expect reiter oper burn year reiter increment income/expens interest debt facil libor drawn due oper comp oper net incom count mm gross oper consensu estim cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
risk includ limit custom adopt could slower expect
averag risk non-invas prenat test reimburs clinic guidelin hurdl
intens competit expect lead greater expect share loss
price eros less expect contribut non-panorama product
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock thermo fisher scientif secur
cowen compani llc manag co-manag public offer past month
cowen compani llc receiv compens invest bank servic past month
past month client cowen compani llc cowen compani llc provid provid invest bank servic
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen credit research trade due natur fix incom market issuer debt secur issuer discuss cowen credit research trade
research report assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon
analysi reflect analyst opinion date report expect continu analysi addit report relat issuer debt secur
time time cowen credit research trade research analyst provid invest recommend secur subject report
recommend intend time date public within paramet specifi individu report cowen credit research trade
invest recommend made strictli case-by-cas basi recommend provid part overarch rate system set consist
appli benchmark view express report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc may et dissemin may et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
